| Dr Shaukat Hayat, MD | |
|
145 Hospital Ave, Suite 102, Du Bois, PA 15801-1462 | |
| (814) 375-3915 | |
| (814) 375-3712 |
| Full Name | Dr Shaukat Hayat |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 145 Hospital Ave, Du Bois, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316953631 | NPI | - | NPPES |
| 1011907350001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD-036504-L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shaukat Hayat, MD 145 Hospital Ave, Suite 102, Du Bois, PA 15801-1462 Ph: (814) 375-3915 | Dr Shaukat Hayat, MD 145 Hospital Ave, Suite 102, Du Bois, PA 15801-1462 Ph: (814) 375-3915 |
News Archive
Elixir Medical Corporation, a developer of innovative drug eluting stent platforms for the treatment of cardiovascular disease, today announced two key presentations scheduled for the 2010 EuroPCR meeting featuring the company's cardiovascular innovations.
4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data on vidofludimus - its lead small-molecule drug candidate against autoimmune diseases - in systemic lupus erythematosus at EULAR 2011, Europe's largest scientific conference on rheumatic diseases, in London, UK, from May 25-28, 2011.
The association between post-traumatic stress disorder and mental health-related quality of life among individuals with bipolar disorder may be mediated by depressive symptoms, the results of a US study indicate.
ImmuPharma PLC the specialist discovery and development pharmaceutical company is pleased to announce today the final results from a Phase IIb trial of LUPUZOR™ in active patients with Systemic Lupus Erythematosus (SLE). Lupuzor™ administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care.
People who identify as African-American may be as little as 1 percent West African or as much as 99 percent, just one finding of a large-scale, genome-wide study of African and African-American ancestry released today.
› Verified 7 days ago
Dr. Manish Ranjan, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 145 Hospital Ave Ste 106, Du Bois, PA 15801 Phone: 814-503-4433 Fax: 814-503-4435 |